Atlas Trials

JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia

Clinical trial NCT06940960 · RECRUITING

Trial details

NCT number
NCT06940960
Sponsor
Affiliated Hospital of Guangdong Medical University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
B Acute Lymphoblastic LeukemiaB-Non Hodgkin Lymphoma
Start date
2025-05-30
Primary completion
2027-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.